Use this Pathway for:

highlighted node

Pathway Description:

Angiogenesis is the formation of new blood vessels and can be induced by tumor growth, tissue wound, and inflammation. Rapid tumor cell growth creates intracellular hypoxia. Hypoxia-inducible factor (HIF) is a transcription factor that responds to changing intracellular oxygen concentration. Under typical oxygen levels (normoxia), HIF is hydroxylated and acetylated, modifications that target the transcription factor for VHL-mediated ubiquitin degradation. During hypoxia, HIF accumulates and is transported to the nucleus where it induces expression of numerous target gene products. Secreted growth factors (such as VEGF, FGF, and TGF) induce signaling pathways (including PLCγ, PI3K, Src, and Smad signaling) that result in endothelial cell proliferation, increased vascular permeability, and cell migration. In addition to hypoxia, the PI3K and Ras pathways can increase HIF expression by promoting HIF translation.

Pericytes are support cells that provide structural support for newly formed blood vessels, promote endothelial cell survival, guide sprouting vessels, and regulate vasoconstriction and dilation. This is done through a reciprocal signaling mechanism in which PDGF-BB secreted into the matrix by endothelial cells acts as a ligand for PDGF receptor-β located on the pericyte membrane. In return, pericytes produce and secrete VEGF that signals through the endothelial VEGF receptor.

Extracellular matrix proteases and regulators induce tissue matrix remodeling in preparation for migration of endothelial cells from existing vessels to form new tubing. Tissue wounding, ischemia, or inflammation recruit macrophages and bone marrowderived inflammatory cells (BDMC) to wound areas and secrete a similar panel of proteins to induce angiogenesis.

Selected Reviews:


created September 2008

revised October 2012